some image

HHI Symposium

MELBOURNE 2018 SPEAKER TIMETABLE

SATURDAY SPEAKER  
9.40 - 9.45am Sharlene Mavor Welcome
9.45 - 10.25am Dr Sanjay Nijhawan Cannabis Access Clinics
10.25 - 11.20am Paul Mavor Health House Internationa
11.20 - 12.05pm Lisa Todd Epilepsy Action Australia
12.05 - 12.40pm Prof Ian Brighthope Entoura 
12.40 - 1.40pm Symposium Lunch Break - Lick & Laugh with Ess & Allan
1.40 - 2.15pm Richard Evans Mirreco Building
2.15 - 2.50pm James Vosper Australian Industrial Hemp Alliance
2.50 - 3.20pm Tim Oates Delta Tetra Consultancy
3.20 - 3.55pm Gary Rogers Hemp Homes Australia
3.55 - 4.35pm Prof Niting Mantri RMIT
4.35 - 5.15pm Rebecca Williams CBD Made Easy
5.15 - 6.20pm Dr Sanjay Nijhawan, Lisa Todd, Paul Mavor, Sharlene Mavor, Leah Bisiani, Rebecca Williams, Prof Ian Brighthope Q & A Panel
SUNDAY SPEAKER  
10.05 - 10.10am Sharlene Mavor WELCOME
10.10 - 10.55am Prof Ian Brighthope Entoura 
10.55 - 11.25am Damian Donoghue SuperHealth
11.25 - 11.55am Rhys Cohen Lambert Initiative
11.55 - 12.35pm Leah Bisiani Uplifting Dementia
12.35 - 1.05pm Paul Mavor Health House International
1.05 - 1.35pm Greg Chipp Drug Policy Australia
1.35 - 2.10pm Carol Ireland/Lisa Todd Epilepsy Action Australia
2.10 - 2.40pm Adam Miller Budding Tech
2.40 - 3.50pm Carol Ireland, Lisa Todd, Paul Mavor, Sharlene Mavor, Prof Ian Brighthope, Leah Bisiani, Rebecca Williams, Rhys Cohen Q & A Panel
3.50pm Sharlene Mavor CLOSE

 

   Timetable - Click for download and print version


  • some image
  • PROFESSOR IAN E. BRIGHTHOPE - Nutritional and Environmental Medicine

    Professor Ian Brighthope has had a lifelong interest in nature. The Brighthope Clinics and Biocentres were developed in the 1970’s and specialised in Nutritional Medicine, Environmental Medicine and Herbal Medicine. As chairman of the Australian College of Herbal Medicine, he developed an early interest in cannabis and other illicit herbs.

  • As founding president of Australasian College of Nutritional and Environmental Medicine (ACNEM) for over 26 years, Professor Brighthope pioneered the first post-graduate medical course in nutrition in Australia. He is now the official ambassador of ACNEM and official ambassador to the peak body Complementary Medicines Australia (CMA). Professor Brighthope’s lifelong ambition is to help change the way medicine and healthcare is practiced for the benefit of the public and to see nutrition, nutritional and environmental medicine and herbal medicine become the building blocks and keystones to world health and peace.

  • some image
  • Adam Miller - Founder of BuddingTech and The Medical Cannabis Council

    Adam completed his studies of Business Entrepreneurship at Royal Melbourne Institute of Technology and Sweden's Jönköping University for international business in 2009. In 2015, Adam became involved in the medical cannabis space due to his passion for the medicine and belief in innovation stimulating its growth. In 2016, Adam founded BuddingTech, Australia's first medical cannabis accelerator program. As CEO of BuddingTech, Adam has worked tirelessly developing networks and collaborations, including the facilitation and management of three student research projects on medical cannabis in conjunction with the University of Sydney's Business School and MGC Pharmaceuticals, producing Australia's first Medical Cannabis White Paper. With strong connections in the startup ecosystem and the medical cannabis industry, Adam recently hosted Australia's first medical cannabis innovation event 'Seedlings'. Additionally, Adam also founded the Medical Cannabis Council, Australia's first national industry body to represent the medical cannabis industry in Australia. The Mission of the Medical Cannabis Council is to create a unifying voice for the medical cannabis industry in Australia, facilitating a framework of best practice and supporting the positioning of Australia as a world leader in research.

  • some image
  • Carol Ireland - CEO and Managing Director of Epilepsy Action Australia

    Carol has an extensive background spanning 35 years in the not-for-profit human services sector and holding a variety of executive positions in operations, service delivery, marketing and fundraising. Carol currently serves on the Australian Advisory Council for the Use of Medicinal Cannabis, the Advisory Board of the Lambert Initiative for Cannabinoid Therapeutics at the University of Sydney and Steering Committee for the NSW government's Paediatric Epilepsy Trials (Medicinal Cannabis Research), and is a founding Director of the newly constituted Medicinal Cannabis Council. In her role at Epilepsy Action she has had significant contact with many individuals and families who are faced with managing very challenging forms of medication resistant epilepsy, with few or no options left in the conventional treatment bucket. Carol has heard and seen the changes in people's lives, including reduction in the severity and frequency of seizures, resulting from use of medicinal cannabis. She is a strong and active advocate for people living with epilepsy.

  • some image
  • Lisa Todd - Clinical Nurse and Clinical Governance Manager for Epilepsy Action Australia

    A Registered Nurse with a Post Graduate Certificate in Neuroscience Nursing and Masters of Education, Lisa is a trained cannabis nurse, having attended numerous educational seminars, conferences and master classes for health care professionals in the United States and Australia.

    She was the lead investigator and co-author on 'An Australian nationwide survey on medicinal cannabis use for epilepsy: History of antiepileptic drug treatment predicts medicinal cannabis use' published in Epilepsy & Behaviour (2017) and Co-investigator in the PELICAN study (Paediatric Epilepsy Lambert Initiative Cannabinoid Analysis) with the University of Sydney. Prior to her work in the field of Medicinal Cannabis Lisa was seconded to the George Research Institute for Global Health for several years as Research Fellow for the SEMISIC study (Sydney Epilepsy Incidence Study to Measure Illness Consequences).

  • some image
  • TIM OATES - Co-Founder and Chief Executive Officer for Delta Tetra Consultancy

    Prior to moving to Australia in 2015, Tim was prominently involved in the UK medical cannabis initiative, working with some of the industry's global leaders and has acquired a comprehensive cannabis industry knowledge-set and network base. Tim has worked tirelessly to innovate and progress sensible approaches to cannabis legislation across Europe. This has led to an applicable and practical knowledge of the cannabis industry globally as well as a wealth of experience in medical cannabis and its relating nuances.

  • Tim is responsible for the daily management of Delta Tetra and client care.

  • some image
  • RICHARD EVANS - Chief Executive Officer – Mirreco

    Mirreco have been recognised as an emerging force in the hemp industry. Mirreco's innovative technologies use hemp biomass to permanently store carbon dioxide above ground in an efficient and very cost-effective manner.

  • Australia is emerging as a leader in hemp farming practices and the development and manufacture of hemp-based products, and we will be collaborating with stakeholders in the hemp and construction industries to support large scale hemp cultivation and processing through the use of our innovative new processing machine.

  • some image
  • CHRIS FAIRMAN - Managing Director - Mirreco

    We manufacture panels using hemp biomass to create energy - efficient housing and commercial structures that are carbon negative, self - sustainable and environmentally friendly. At the prestigious 2017 Australian National Sustainability Awards we were awarded runner-up status for product innovation from over 100 applicants using our innovative hemp panels.

  • Mirreco was invited to join ASBEC (Australian Sustainable Built Environmental Council) and are now a council member. ASBEC is the peak body of key organisations committed to a sustainable built environment in Australia.

  • some image
  • Sharlene Mavor – Medical Cannabis Research Australia (NFO) - Melbourne 2018 Symposium - MC

    Sharlene is a Medical Scientist (BAppSc -Medical Laboratory Science) and director of Medical Cannabis Research Australia who has been researching how Medical Cannabis may treat an ever-increasing array of disorders. Her university background in diagnostic pathology gives her the knowledge to understand disease processes in the human body. She’s travelled to the US, Canada, Israel, Colombia and Chile to learn firsthand from the leading researchers in this new field of cannabinoid science.

  • She’s passionate about sharing this knowledge by educating others under the banner of her charity Medical Cannabis Research Australia. She is committed to advocating for use and access to medical cannabis for patients in Australia as well as promoting more research to give clinicians the evidence they require to pursue this treatment for their patients, both in Australia and in the rest of the world.

  • some image
  • Paul Mavor - Health House International

    Paul is a registered Australian and UK pharmacist. His company Health House was granted the first medicinal cannabis import license in Australia and he is currently distributing medicinal cannabis products to eligible patients.

  • Over the last 30 years he has owned several retail pharmacies and worked both in Australia and the UK.

  • In the last 3 years he has focussed on researching medicinal cannabis and has been to conferences, grow and manufacturing facilities and spoken to patients and prescribers in the US, Canada, Israel and recently South America. www.healthhouse.com.au

  • some image
  • Leah Bisiani - Dementia Consultant/Learning & Advisory

    Leah Bisiani has 35 years’ experience within aged /dementia care, establishing a highly skilled knowledge basis as a global leader in this field. Her primary vision has focused on changing negative cultures and philosophies of care associated with people living with dementia, providing a voice that confronts current practice and advocates their rights.

  • Her pioneering revelations enable people living with dementia to attain enriched lifestyles that enable continuation of life based on recognition of the person, valuing individual preference and choices. Additionally, Leah advocates the therapeutic attributes of medicinal cannabis.

  • She has become a popular and prominent speaker at other foremost Australian and Global medicinal cannabis conferences, symposiums and summits, deliberating the promising therapeutic benefits of medicinal cannabis for the treatment of chronic intractable pain in the older population.

  • some image
  • Dr Sanjay Nijhawan - Cannabis Access Clinics

    Dr Sanjay Nijhawan was appointed as Medical Director to help drive the clinical governance and expansion strategy for Cannabis Access Clinics throughout Australia. Dr Nijhawan is also the Director and part owner of the Specialist Medical Services, in Sydney involved in the management of various private hospitals, Day Surgeries, Eye Centres and specialist clinics. Throughout his career Dr Nijhawan has held a number of senior management roles including Head of Clinical Development at Primary Healthcare and was also medical director and practice principal at a number of general medical practices.

  • Cannabis Access Clinics are focussed on helping doctors and patients navigate the regulatory pathway for prescribing medicinal cannabis products in Australia. Our clinics work closely with patients who suffer from indications for which there is some evidence that medicinal cannabis therapies may be beneficial.

  • some image
  • RHYS COHEN - Lambert Initiative for Cannabinoid Therapeutics

    Rhys is a political economist, cannabis expert and educator. Rhys acts as a key interface between the Lambert Initiative and government, regulators, industry and consumers. He is responsible for leading a variety of projects within the Initiative to do with policy; operations management; regulation; industry engagement; and consumer outreach.

  • Rhys has appeared in major news outlets including the Sydney Morning Herald, The Age, and MJBizDaily, and his industry analysis has been cited by Deloitte Access Economics, the Victorian Department of Economic Development, Jobs, Transport and Resources, and the Commonwealth Office of Drug Control. He has also spoken on the political, regulatory and economic features of medicinal cannabis at events across Australia and internationally.

  • some image
  • Greg Chipp - Director Drug Policy Australia

    Drug Policy Australia is a Health Promotion Charity and NGO that advocates for evidence-based, Harm Reduction drug policies. Criminalising drug users is counterproductive and a new regulatory system based on the 'Portugal Model' of decriminalising the personal drug use is the only solution to Australia's drug problems. Greg has been active in politics and public policy development for several decades, beginning with the Australian Democrats.

  • In 2012, Greg founded a single issue Political Party called Drug Law Reform Australia to raise awareness about the ongoing harm being done to young people and families by unrealistic drug laws that criminalise millions of otherwise law-abiding Australians. At the 2106 Federal election, the party ran a successful "Free Cannabis" campaign calling for the full legalisation of Cannabis. Greg supports the right of all Australians to access medicines they deem appropriate without fear of criminal prosecution.

  • some image
  • REBECCA WILLIAMS presents "CBD Made Easy"

    Rebecca is a former pharmaceutical worker & advocate of CBD and all its benefits. She is in her third year of her science degree majoring in biology & chemistry. She recently switched her focus from pharmacy to science to pursue other more meaningful passions.

  • The book "CBD Made Easy" was written with the purpose of simplifying how CBD works in the human body, listing all the known ailments CBD can alleviate and then directly referencing the related medical studies all in one short publication. After reading this short book, patients should be able to approach their health professional with a reasonable understanding of how CBD will help them and a direction for utilising CBD as part of their treatment.

  • some image
  • Gary Rogers - Hemp Homes Australia

    Gary is the owner of one of Australia’s long established and largest hemp retail business, the Margaret River Hemp Co. He is also owner/builder of Hemp Homes Australia. His main advocacy is to promote the Australian Hemp Industry, by using only Australian Hemp Building products, whilst also supporting local industries.

  • Throughout his long involvement with Industrial Hemp, Gary’s philosophy is to promote the many benefits of Industrial Hemp. From the primary source of growing hemp, to its many products, including clothes, fabric, bodycare, food and now the building industry

  • some image
  • James Vosper - speaker for AIHA

    It was James' passion for the environment that led to his first involvement in industrial hemp in 2009. His interest in all aspects of industrial hemp soon expanded and he has addressed many forums on the benefits of hemp for the economy, the environment, as food and as medicine.

  • James is speaking on behalf of the Autralian Industrial Hemp Alliance, an organisation whose members have been prime movers in the legalisation of hemp as food. He is President of the Australian Industrial Hemp Alliance (AIHA) a national organisation representing members from all Australian states. He is also the Chair of the AIHA sub-committee on medicinal cannabis. 

  • some image
  • Dr Nitin Mantri - RMIT

    Dr Nitin Mantri is Associate Professor of Biotechnology, Program Manager for Master of Biotechnology, and Chair of Next Generation Sequencing Facility within the School of Science, RMIT University. He is the Founding Member of Medical Cannabis Council, Australia and on the Medical Cannabis Advisory Board, Pennsylvania. His research is focused on Plant Functional Genomics and Pharmacogenomics. He has published 65 research articles, majority being published in ‘Q1’ Journals. All his projects are industry focused and involve tangible benefits for industries like GRDC, Pulse Breeding Australia, Horticulture Innovation Australia Ltd, Strawberries Australia, Sanitarium Health Foods, Stiefel Research Australia, MGC Pharmaceuticals, and Kenkay Pharmaceuticals.

  • Recently, he established a $1.5 million project with MGC Pharmaceuticals for breeding and pre-clinical analysis of medical cannabis. Along with developing anti-cancer strains, they will be producing a cannabinoid database to help patients, researchers and doctors to choose the right strain.

  • some image
  • Damian Donoghue - Superhealth

    After many years of diet changes, constant detoxing and re-educating himself, Damian completely turned his health around and healed himself of Chronic Fatigue.

    What started as one individuals journey to heal himself naturally of Chronic Fatigue Syndrome has now grown exponentially into the SuperHealth community of health and wellness enthusiasts committed to sharing knowledge, providing support and guidance and bringing you the highest quality superfoods and detoxification products in the world.

    Damian is super passionate about using cannabis to enhance human health and he loves sharing fun and practical ways to include cannabis in your family’s daily health regime.

Want TO BE AN EXHIBITOR?

The Melbourne HHI Expo 2018 is in December. It will be held over two days commencing Saturday 8th December and Sunday 9th December 2018, we invite you to contact us for more details including Log In information that will be available after June 2018. Secure your spot. Get in early so you do not miss out on this special event!